Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Non-cash Items (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Non-cash Items for 15 consecutive years, with $9000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items fell 99.1% to $9000.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $9000.0, a 99.1% decrease, with the full-year FY2025 number at $9000.0, down 99.1% from a year prior.
  • Non-cash Items was $9000.0 for Q4 2025 at Cryo Cell International, down from $422845.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $3.6 million in Q4 2021 to a low of $9000.0 in Q4 2025.
  • A 5-year average of $865463.8 and a median of $410937.0 in 2022 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: soared 1672.86% in 2024, then tumbled 99.1% in 2025.
  • Cryo Cell International's Non-cash Items stood at $3.6 million in 2021, then crashed by 98.95% to $37250.0 in 2022, then skyrocketed by 263.3% to $135330.0 in 2023, then surged by 637.41% to $997943.0 in 2024, then crashed by 99.1% to $9000.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Non-cash Items are $9000.0 (Q4 2025), $422845.0 (Q3 2025), and $425995.0 (Q2 2025).